MedPath

Treatment of Asthma (difficulty in breathing) by Unani medicine Laooq-e- Zeequn Nafas

Phase 3
Conditions
Health Condition 1: J452- Mild intermittent asthma
Registration Number
CTRI/2020/02/023639
Lead Sponsor
Central Council for Research in Unani Medicine CCRUM New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Males and females of 18-65 years.

2.Patients of Bronchial Asthma for at least 6 months presenting with at least one of the following symptoms:

a.Wheeze

b.Shortness of breath

c.Chest tightness and cough that vary over time and in intensity,

d.Expiratory airflow limitation as suggested by

a decreased FEV1

3.Objective evidence for reversible airway obstruction (>=12% and >=200 mL change in FEV1 and/or a 25% and 60 L/min change in PEFR) either spontaneously or after treatment.

4.Patients with Asthma Control Questionnaire Score > 1.5.

Exclusion Criteria

1.FEV1/FVC ratio < 50%

2.Pregnant and lactating mother

3.Patient with other Respiratory Tract Infections, tuberculosis and malignancy.

4.Patient of Presence of chronic cough with expectoration for 2-3 months in each of 2 successive years.

5.Patient with co-morbidities, Diabetes Mellitus, Hepatic and Renal Insufficiency.

6.Patients with Tobacco Smoking.

7.Patient with regular use of oral or systemic corticosteroids for conditions other than Asthma.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath